Mitochondrial dysfunctions in Parkinson's disease

Revue Neurologique

Volumn 170, Issue 5, 2014, Pages 339-343

  Gautier, C A ^a,b,c   Corti, O ^a,b,c   Brice, A ^a,b,c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c CNRS   (France)

Author keywords

Disease models; Mitochondria; Oxidative stress; Parkinson's Disease

Indexed keywords

ALPHA SYNUCLEIN; ANTIOXIDANT; LEUCINE RICH REPEAT KINASE 2; MITOCHONDRIAL DNA; PARKIN; QUERCETIN; TOCOPHEROL;

BRAIN DISEASE; BRAIN MITOCHONDRION; DEGENERATIVE DISEASE; DISEASE MODEL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOPAMINERGIC NERVE CELL; GENE MUTATION; GENETIC MODEL; HUMAN; IDIOPATHIC DISEASE; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; REVIEW; COMPLICATION; GENETIC PREDISPOSITION; GENETICS; MITOCHONDRIAL DISEASES; MITOCHONDRION; PHYSIOLOGY;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; PARKINSON DISEASE;

EID: 84901243996     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2013.06.003     Document Type: Review

References (49)

1. Z.I. Alam, A. Jenner, S.E. Daniel, A.J. Lees, N. Cairns, and C.D. Marsden et al. Oxidative DNA damage in the Parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra J Neurochem 69 1997 1196 1203
2. A. Barbeau, L. Dallaire, N.T. Buu, J. Poirier, and E. Rucinska Comparative behavioral, biochemical and pigmentary effects of MPTP, MPP+ and paraquat in Rana pipiens Life Sci 37 1985 1529 1538
3. A. Bender, K.J. Krishnan, C.M. Morris, G.A. Taylor, A.K. Reeve, and R.H. Perry et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease Nat Genet 38 2006 515 517
4. R. Benecke, P. Strümper, and H. Weiss Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes Brain 116 Pt 6 1993 1451 1463
5. R. Betarbet, T.B. Sherer, G. MacKenzie, M. Garcia-Osuna, A.V. Panov, and J.T. Greenamyre Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nat Neurosci 3 2000 1301 1306
6. E. Cadenas, A. Boveris, C.I. Ragan, and A.O. Stoppani Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c reductase from beef-heart mitochondria Arch Biochem Biophys 180 1977 248 257
7. I.E. Clark, M.W. Dodson, C. Jiang, J.H. Cao, J.R. Huh, and J.H. Seol et al. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin Nature 441 2006 1162 1166
8. O. Corti, and A. Brice Mitochondrial quality control turns out to be the principal suspect in parkin and PINK1-related autosomal recessive Parkinson's disease Curr Opin Neurobiol 23 1 2013 100 108
9. O. Corti, S. Lesage, and A. Brice What genetics tells us about the causes and mechanisms of Parkinson's disease Physiol Rev 91 2011 1161 1218
10. H. Deng, M.W. Dodson, H. Huang, and M. Guo The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila Proc Natl Acad Sci USA 105 2008 14503 14508
11. D. Dexter, C. Carter, F. Agid, Y. Agid, A.J. Lees, and P. Jenner et al. Lipid peroxidation as cause of nigral cell death in Parkinson's disease Lancet 2 1986 639 640
12. C.A. Gautier, T. Kitada, and J. Shen Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress PNAS 105 2008 11364 11369
13. S. Gispert, F. Ricciardi, A. Kurz, M. Azizov, H.-H. Hoepken, and D. Becker et al. Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration PLoS One 4 2009 e5777
14. J.C. Greene, A.J. Whitworth, I. Kuo, L.A. Andrews, M.B. Feany, and L.J. Pallanck Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants Proc Natl Acad Sci USA 100 2003 4078 4083
15. H.-H. Hoepken, S. Gispert, B. Morales, O. Wingerter, D. Del Turco, and A. Mülsch et al. Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6 Neurobiol Dis 25 2007 401 411
16. G.U. Höglinger, J. Féger, A. Prigent, P.P. Michel, K. Parain, and P. Champy et al. Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats J Neurochem 84 2003 491 502
17. S.D. Iversen, and L.L. Iversen Dopamine: 50 years in perspective Trends Neurosci 30 2007 188 193
18. S.S. Karuppagounder, S.K. Madathil, M. Pandey, R. Haobam, U. Rajamma, and K.P. Mohanakumar Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson's disease in rats Neuroscience 236 2013 136 148
19. C. Kondapalli, A. Kazlauskaite, N. Zhang, H.I. Woodroof, D.G. Campbell, and R. Gourlay et al. PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65 Open Biol 2 2012 120080
20. Y. Kraytsberg, E. Kudryavtseva, A.C. McKee, C. Geula, N.W. Kowall, and K. Khrapko Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons Nat Genet 38 2006 518 520
21. J.W. Langston, P. Ballard, J.W. Tetrud, and I. Irwin Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis Science 219 1983 979 980
22. P. Luoma, A. Melberg, J.O. Rinne, J.A. Kaukonen, N.N. Nupponen, and R.M. Chalmers et al. Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study Lancet 364 2004 875 882
23. V.M. Mann, J.M. Cooper, D. Krige, S.E. Daniel, A.H. Schapira, and C.D. Marsden Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease Brain 115 Pt 2 1992 333 342
24. V.A. Morais, P. Verstreken, A. Roethig, J. Smet, A. Snellinx, and M. Vanbrabant et al. Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function EMBO Mol Med 1 2009 99 111
25. H. Mortiboys, K.J. Thomas, W.J.H. Koopman, S. Klaffke, P. Abou-Sleiman, and S. Olpin et al. Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts Ann Neurol 64 2008 555 565
26. D. Narendra, A. Tanaka, D.-F. Suen, and R.J. Youle Parkin is recruited selectively to impaired mitochondria and promotes their autophagy J Cell Biol 183 2008 795 803
27. W.J. Nicklas, I. Vyas, and R.E. Heikkila Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine Life Sci 36 1985 2503 2508
28. K. Okatsu, T. Oka, M. Iguchi, K. Imamura, H. Kosako, and N. Tani et al. PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria Nat Commun 3 2012 1016
29. J. Olesen, A. Gustavsson, M. Svensson, H.-U. Wittchen, B. Jönsson on behalf of the CDBE2010 study group, and the European Brain Council The economic cost of brain disorders in Europe Eur J Neurol 19 2012 155 162
30. J.J. Palacino, D. Sagi, M.S. Goldberg, S. Krauss, C. Motz, and M. Wacker et al. Mitochondrial dysfunction and oxidative damage in parkin-deficient mice J Biol Chem 279 2004 18614 18622
31. J. Park, S.B. Lee, S. Lee, Y. Kim, S. Song, and S. Kim et al. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin Nature 441 2006 1157 1161
32. T.L. Perry, and V.W. Yong Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients Neurosci Lett 67 1986 269 274
33. Pilsl, A. Winklhofer, and K.F. Parkin PINK1 and mitochondrial integrity: emerging concepts of mitochondrial dysfunction in Parkinson's disease Acta Neuropathol 123 2012 173 188
34. M.H. Polymeropoulos, C. Lavedan, E. Leroy, S.E. Ide, A. Dehejia, and A. Dutra et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease Science 276 1997 2045 2047
35. A.C. Poole, R.E. Thomas, L.A. Andrews, H.M. McBride, A.J. Whitworth, and L.J. Pallanck The PINK1/Parkin pathway regulates mitochondrial morphology Proc Natl Acad Sci USA 105 2008 1638 1643
36. A. Schapira Mitochondrial complex i deficiency in Parkinson's disease Lancet 333 1989 1269
37. K. Sriram, K.S. Pai, M.R. Boyd, and V. Ravindranath Evidence for generation of oxidative stress in brain by MPTP: in vitro and in vivo studies in mice Brain Res 749 1997 44 52
38. A.H. Schapira Mitochondria in the aetiology and pathogenesis of Parkinson's disease Lancet Neurol 7 1 2008 97 109
39. G. Siciliano, M. Mancuso, R. Ceravolo, V. Lombardi, A. Iudice, and U. Bonuccelli Mitochondrial DNA rearrangements in young onset Parkinsonism: two case reports J Neurol Neurosurg Psychiatry 71 5 2001 685 687
40. C.C. Stichel, X.-R. Zhu, V. Bader, B. Linnartz, S. Schmidt, and H. Lübbert Mono- and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage Hum Mol Genet 16 2007 2377 2393
41. C.M. Testa, T.B. Sherer, and J.T. Greenamyre Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures Brain Res Mol Brain Res 134 2005 109 118
42. R.J. Tolwani, M.W. Jakowec, G.M. Petzinger, S. Green, and K. Waggie Experimental models of Parkinson's disease: insights from many models Lab Anim Sci 49 1999 363 371
43. E.M. Valente, P.M. Abou-Sleiman, V. Caputo, M.M.K. Muqit, K. Harvey, and S. Gispert et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1 Science 304 2004 1158 1160
44. S. Vilain, G. Esposito, D. Haddad, O. Schaap, M.P. Dobreva, and M. Vos et al. The yeast complex I equivalent NADH dehydrogenase rescues pink1 mutants PLoS Genet 8 2012 e1002456
45. M. Vos, G. Esposito, J.N. Edirisinghe, S. Vilain, D.M. Haddad, and J.R. Slabbaert et al. Vitamin K2 is a mitochondrial electron carrier that rescues pink1 deficiency Science 336 2012 1306 1310
46. T.V. Votyakova, and I.J. Reynolds DeltaPsi(m)-Dependent and -independent production of reactive oxygen species by rat brain mitochondria J Neurochem 79 2001 266 277
47. Y. Yang, S. Gehrke, Y. Imai, Z. Huang, Y. Ouyang, and J.-W. Wang et al. Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin Proc Natl Acad Sci USA 103 2006 10793 10798
48. Y. Yang, Y. Ouyang, L. Yang, M.F. Beal, A. McQuibban, and H. Vogel et al. Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery Proc Natl Acad Sci USA 105 2008 7070 7075
49. J. Zhang, G. Perry, M.A. Smith, D. Robertson, S.J. Olson, and D.G. Graham et al. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons Am J Pathol 154 1999 1423 1429